SCHEMBL28209554

SCHEMBL28209554

CC1CC(NCc2ccccc2C(=O)O)CC(C)(C)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 3/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
HIF1A Q16665 1/20 0.39
BRD4 O60885 1/20 0.39
IDH1 O75874 2/20 0.38
PPP1CA P62136 1/20 0.38
FOLH1 Q04609 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13476626 0.81 ALDH1A1 (0.43) ALDH1A1HTTHIF1ABRD4FOLH1
SCHEMBL791741 0.80 VEGFA (0.50) ALDH1A1HTTHIF1ABRD4FOLH1
SCHEMBL28209595 0.78 ALDH1A1 (0.52) ALDH1A1HTTNPSR1TDP1IDH1
SCHEMBL28216889 0.73 ALDH1A1 (0.44) ALDH1A1HTTLMNACYP3A4CYP2C9
SCHEMBL28216891 0.73 ALDH1A1 (0.44) ALDH1A1HTTLMNACYP3A4CYP2C9
SCHEMBL1182205 0.71 SLC6A2 (0.51) ALDH1A1HTTHIF1ABRD4FOLH1
SCHEMBL7827812 0.70 ALDH1A1 (0.46) ALDH1A1HTTLMNACYP3A4CYP2C9
SCHEMBL21088501 0.69 KDM1A (0.40) ALDH1A1HTTHIF1ABRD4FOLH1
SCHEMBL10896432 0.68 TDP1 (0.52) ALDH1A1HTTLMNACYP3A4CYP2C9
SCHEMBL28209533 0.68 ALDH1A1 (0.47) ALDH1A1HTTLMNACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026052-A 5-hydroxyalkyl benzimidazoles as mIDH1 inhibitors 拜耳制药股份公司 2018-05-11 CN disclosed
CN-107949557-A 2 aryl and 2 aralkyl benzimidazoles as mIDH1 inhibitor 拜耳制药股份公司 2018-04-20 CN disclosed